Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05100121 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

To Live Better After Prostate Cancer Treatment:

Study acronym: CAPPRIS
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Enrollment target: 140 to 40v4 Show 8 more changesShow less
    • Primary endpoints: 2 to 4
    • Primary completion date: May 1, 2025 to Jun 1, 2025
    • Study completion date: Dec 1, 2026 to Dec 25, 2025
    • Start date: Nov 1, 2023 to Oct 17, 2023
    • Interventions: Interactive app (Device), Survivor-ship care (Other) to Interactive app (Device), Supportive Care (Other)
    • Secondary endpoints: 3 to 6
    • Study description expanded, about 18 words
    • Study title shortened, about 1 word
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: May 2024 to May 1, 2025
    • Start date changed from estimate of Aug 2022 to Nov 1, 2023
    • Study sites: 0 to 1
    • Study completion date: Aug 2024 to Dec 1, 2026
  4. Start date: Jan 2022 to Aug 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
It is evident that patients receiving treatment for cancer have symptoms that often are undetected. Furthermore, many survivors from cancer have ongoing poor health and well-being and long-term rehabilitation and support should not be neglected to prevent recurrence and increase survival. There are good reasons to believe that routine collection of relevant patient-reported symptoms facilitates person-centered care where the patient is a participatory member of the team. This study aims to pilot-test a supportive intervention in primary care for six months during the first year after primary treatment for prostate cancer in primary care and compare it to standard care only. The intervention consists of symptom reporting and self-management in an app in combination with health dialogues with a study-specific nurse at a primary care centre.
Trial Details
NCT Number NCT05100121
Lead Sponsor Karolinska Institutet
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov